Titre
Targeted therapies and precision medicine for inflammatory skin diseases.
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Gilliet, M.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1952-4013
Statut éditorial
Publié
Date de publication
2019-04-01
Volume
29
Numéro
S1
Première page
19
Dernière page/numéro d’article
24
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Over the last years, several immune pathways in the skin have been identified. These discoveries have been translated into targeted therapies for inflammatory skin diseases, which have revolutionized our clinical practice. The perturbed molecular network in the skin may serve as a biomarker for disease prediction and as a source of targets for early therapeutic intervention or prevention. With rising costs, this disease-focused healthcare model will become unsustainable, therefore next-generation healthcare must not focus solely on treatment personalisation (the right treatment for the right patient), but also needs to shift its focus towards disease prevention and early therapeutic intervention prior to disease manifestation.
PID Serval
serval:BIB_D1783F3F5763
PMID
Date de création
2019-04-28T14:43:11.138Z
Date de création dans IRIS
2025-05-21T03:01:38Z